Compare ENGN & MAMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENGN | MAMA |
|---|---|---|
| Founded | 1999 | 2010 |
| Country | Canada | United States |
| Employees | 82 | N/A |
| Industry | | Specialty Foods |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.9M | 598.8M |
| IPO Year | N/A | 2011 |
| Metric | ENGN | MAMA |
|---|---|---|
| Price | $1.64 | $15.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $21.08 | $19.00 |
| AVG Volume (30 Days) | ★ 3.6M | 364.3K |
| Earning Date | 06-11-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 44.44 |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $95,420,129.00 |
| Revenue This Year | N/A | $31.09 |
| Revenue Next Year | N/A | $16.12 |
| P/E Ratio | ★ N/A | $117.46 |
| Revenue Growth | N/A | ★ 95.54 |
| 52 Week Low | $1.40 | $7.75 |
| 52 Week High | $12.25 | $17.85 |
| Indicator | ENGN | MAMA |
|---|---|---|
| Relative Strength Index (RSI) | 29.13 | 56.73 |
| Support Level | $1.40 | $14.43 |
| Resistance Level | $1.87 | $16.75 |
| Average True Range (ATR) | 0.11 | 0.65 |
| MACD | 0.20 | 0.09 |
| Stochastic Oscillator | 37.84 | 69.52 |
enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs. Its pioneering program is detalimogene voraplasmid (also known as detalimogene) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene in high-risk, Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (CIS) with or without concomitant papillary disease. It is developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX) platform.
Mama's Creations Inc manufactures and markets fresh deli-prepared foods distributed through grocery, mass, club, and convenience stores across the United States. Its product portfolio includes refrigerated prepared foods such as meatballs, meatloaf, sausage products, and pasta and rice entrees. The products are principally sold to supermarkets, club chains, mass-market retailers, and food distributors. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.